Prioritised investments from pharma companies shaping competitive pipeline landscape of… GlobalData Jul 11, 2024 In recent years, bronchiectasis has garnered a significant amount of attention, with pharmaceutical companies prioritising their…
Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion:… GlobalData May 13, 2024 Brensocatib is a dipeptidyl peptidase-1 (DPP-1) reversible inhibitor which exhibits anti-inflammatory action through suppressing…
Bacteria, viruses, and fungi work as a network in causing lung infection: Study EP News Bureau May 20, 2021 Researchers from NTU Singapore find that microbes in the body exist as a network, and that an infection’s severity could be a…
